SFES vs. NUKK, FTII, HSPO, REFR, TPBA, IRAA, FORL, TOP, ISPO, and NRT
Should you be buying Safeguard Scientifics stock or one of its competitors? The main competitors of Safeguard Scientifics include Nukkleus (NUKK), FutureTech II Acquisition (FTII), Horizon Space Acquisition I (HSPO), Research Frontiers (REFR), TPB Acquisition Co. I (TPBA), Iris Acquisition (IRAA), Four Leaf Acquisition (FORL), TOP Financial Group (TOP), Inspirato (ISPO), and North European Oil Royality Trust (NRT). These companies are all part of the "trading" industry.
Safeguard Scientifics vs. Its Competitors
Safeguard Scientifics (NASDAQ:SFES) and Nukkleus (NASDAQ:NUKK) are both small-cap trading companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.
In the previous week, Nukkleus had 2 more articles in the media than Safeguard Scientifics. MarketBeat recorded 2 mentions for Nukkleus and 0 mentions for Safeguard Scientifics. Nukkleus' average media sentiment score of 1.28 beat Safeguard Scientifics' score of 0.00 indicating that Nukkleus is being referred to more favorably in the news media.
53.9% of Safeguard Scientifics shares are held by institutional investors. Comparatively, 12.5% of Nukkleus shares are held by institutional investors. 51.8% of Safeguard Scientifics shares are held by company insiders. Comparatively, 14.9% of Nukkleus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Nukkleus has higher revenue and earnings than Safeguard Scientifics.
Safeguard Scientifics has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Nukkleus has a beta of -6.01, meaning that its stock price is 701% less volatile than the S&P 500.
Safeguard Scientifics' return on equity of -53.75% beat Nukkleus' return on equity.
Summary
Nukkleus beats Safeguard Scientifics on 5 of the 9 factors compared between the two stocks.
Get Safeguard Scientifics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SFES and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SFES and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Safeguard Scientifics Competitors List
Related Companies and Tools
This page (NASDAQ:SFES) was last updated on 7/16/2025 by MarketBeat.com Staff